Biohaven Ltd. Balance Sheet
BHVN / Health Care|5 years of annual SEC 10-K data (FY2020-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Biohaven Ltd. had $615M in total assets and $423M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | $99.1M | $248.4M | $204.9M | $76.1M | $82.5M |
| Current Assets | $538.5M | $442.4M | $587.0M | $94.8M | - |
| PP&E (Net) | $17.3M | $17.2M | $17.5M | $13.0M | - |
| Goodwill | $1.4M | $1.4M | $1.4M | $1.4M | - |
| Total Assets | $615.1M | $513.2M | $661.8M | $142.1M | - |
| Current Liabilities | $154.2M | $55.4M | $90.0M | $41.9M | - |
| Shareholders' Equity | $423.4M | $428.0M | $538.8M | $34.7M | $16.8M |